Physician profile
Babu Jasti
NPI 1417983271
$4,472.39
in general payments reported to CMS, 2019-2025
31 companies · $395 in 2025
The $395 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $718 · 2020: $264 · 2021: $544 · 2022: $766 · 2023: $989 · 2024: $796 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,160 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,159.99 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $653.78 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $564.92 | 2019-2025 | |
| Angiodynamics, INC. | $464.21 | 2023-2024 | Auryon Laser System 100-120 Vac, Alphavac |
| Amgen INC. | $406.53 | 2019-2024 | Repatha |
| Pfizer INC. | $308.64 | 2019-2024 | |
| Abbott Laboratories | $235.78 | 2020-2024 | Pressurewire |
| Boston Scientific Corporation | $172.74 | 2019-2025 | General - Balloon Catheters, Opticross, Watchman |
| Astrazeneca Pharmaceuticals LP | $140.37 | 2019-2025 | Farxiga |
| Medtronic, INC. | $126.02 | 2023-2025 | Corevalve Evolut R, Aquamantys(Tm), Plasmablade(Tm) |
| Esperion Therapeutics, INC. | $125.94 | 2020-2024 | Nexletol |
| Cleerly, INC. | $120.40 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Zoll Circulation INC | $119.14 | 2023 | Downstream Cartridge, Catheter, Therox Ds2 Console |
| Boehringer Ingelheim Pharmaceuticals, INC. | $116.02 | 2022-2025 | Jardiance |
| Astellas Pharma US INC | $105.35 | 2019 | |
| Silk Road Medical, INC. | $94.74 | 2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $91.87 | 2021-2023 | Verquvo |
| Philips North America LLC | $91.30 | 2019-2021 | |
| Lexicon Pharmaceuticals, INC. | $82.14 | 2023-2024 | Inpefa |
| Novo Nordisk INC | $82.00 | 2021-2024 | Rybelsus, Ozempic, Wegovy |
| Cvrx, INC. | $60.31 | 2023 | Barostim Neo System |
| Bayer Healthcare Pharmaceuticals INC. | $51.95 | 2021-2025 | |
| Cardiac Dimensions, INC. | $50.81 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $44.33 | 2023 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $31.49 | 2024 | Eliquis, Camzyos |
| Scpharmaceuticals INC. | $25.97 | 2024 | |
| Arbor Pharmaceuticals, INC. | $24.78 | 2019 | |
| Amarin Pharma, INC. | $20.72 | 2021 | |
| Kestra Medical Technology Services, INC. | $17.45 | 2023 | Assure Wcd |
| Regeneron Healthcare Solutions, INC. | $17.19 | 2019 | |
| Alexion Pharmaceuticals, INC. | $13.78 | 2021 | |
| Gilead Sciences, INC. | $11.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Babu Jasti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.